Recent Updates
Recently added Catalysts
ELAN Negative Sentiment Score: 25/100

Elanco Animal Health Incorporated Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 6, 2024 to Discuss Your Rights – ELAN

Key Takeaway: Elanco Animal Health Incorporated is currently facing a securities fraud class action lawsuit initiated by Levi & Korsinsky, LLP, aimed at recovering losses incurred by investors between November 7, 2023, and June 26, 2024. The lawsuit alleges that Elanco made misleading statements regarding the safety of its product Zenrelia and its potential timelines for U.S. approval and market launch of Zenrelia and Credelio Quattro. As a result, the company’s public communications are claimed to have created an inaccurate perception of its business and financial health, leading to investor losses.

Market Sentiment Analysis

CONCERNS & RISKS

  • Elanco is facing a securities fraud class action lawsuit due to alleged false statements made regarding product safety and approval timelines.
  • Investors may have suffered significant financial losses as a result of misleading public statements and overstated business prospects.
  • The lawsuit claims that the company concealed critical information affecting investor decisions.

Full Press Release Details

NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Elanco Animal Health Incorporated ("Elanco" or the "Company") (NYSE: ELAN) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Elanco investors who were adversely affected by alleged securities fraud between November 7, 2023 and June 26, 2024. Follow the link below to get more information and be contacted by a member of our team:
ELAN investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) Zenrelia, a once-daily oral inhibitor for canine dermatology, was less safe than the Company had led investors to believe; (ii) Elanco was unlikely to meet its own previously issued timeline for the U.S. approval and commercial launch of both Zenrelia and Credelio Quattro, a broad spectrum parasiticide product for dogs; (iii) accordingly, the Company’s business and/or financial prospects were overstated; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.
WHAT'S NEXT? If you suffered a loss in Elanco during the relevant time frame, you have until December 6, 2024 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.
WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 17th Floor

Tags

Frequently Asked Questions

What is the class action lawsuit against Elanco about?

The lawsuit aims to recover losses for investors impacted by alleged securities fraud.

What are the key allegations in the Elanco lawsuit?

The complaint alleges false statements regarding Zenrelia's safety and delayed approvals.

What is the deadline to join the Elanco class action?

Investors must request lead plaintiff status by December 6, 2024.

Do I have to pay to participate in the Elanco lawsuit?

No, class members can participate without any out-of-pocket costs.

Why choose Levi & Korsinsky for the Elanco case?

The firm has a strong track record in securities litigation and extensive experience.

Last updated: Oct 14, 2024